查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1344469

动态多导睡眠图 (PSG) 系统市场：按产品、按应用、按最终用户：2022-2031 年全球机会分析和产业预测

Ambulatory Polysomnography Systems Market By Product, By Application, By End-user : Global Opportunity Analysis and Industry Forecast, 2022-2031
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格

动态多导睡眠图 (PSG) 系统市场预计 2021 年为 3.27 亿美元，2022 年至 2031 年复合年增长率为 6%，到 □□2031 年将达到 5.707 亿美元。

动态多导睡眠图系统市场-IMG1

动态多导睡眠图(Amb-PSG)，也称为II 型PSG，可表征睡眠阶段并量化清醒状态、总睡眠时间(TST) 和准确的呼吸障碍指数(RDI)，可用于识别各种睡眠障碍。 门诊多导睡眠图系统因其优点而受到各种睡眠障碍患者的欢迎。 这正在推动门诊多导睡眠图 (PSG) 系统市场的发展。

大多数人，特别是农村地区的人，并不了解睡眠呼吸中止症的危险。 如果不及时治疗，睡眠障碍可能会导致心臟衰竭、中风、高血压、糖尿病和肥胖等慢性疾病。 这可能会导致严重的健康问题，例如血压失控、心臟病发作、肾臟血管减弱和受限以及动脉瘤。 公众对睡眠障碍认识的缺乏预计将在不久的将来阻碍门诊多导睡眠图测试系统市场的成长。

睡眠护理业务的技术进步可以被认为是该市场的驱动力。 由于便携式设备、智慧型手机应用和远距医疗等众多创新技术的出现，门诊多导睡眠监测 (PSG) 系统市场正在稳步成长。 无线便携式多导睡眠图测试系统（例如 Nox Medical 的 Nox A1s PSG）受益于研究和开发。 无线功能让患者在诊断期间可以自由移动，从而给患者一种自由感。 这可能会对门诊多导睡眠图（PSG）系统市场的成长产生有益的影响。

全球市场受益于 COVID-19 大流行的爆发。 主要参与者声称，由于 COVID-19 大流行导致患有睡眠障碍的患者数量增加，他们的收入大幅增加。 调查显示，自 COVID-19 爆发以来，70% 的受访者经历了一种或多种新的睡眠问题，导致睡眠呼吸中止症的使用增加。 因此，PSG 系统营运商推出了一款经过临床认证的低接触 CPAP 面罩选择工具，可从患者家中远端存取。

目录

第一章简介

第 2 章执行摘要

第三章市场概述

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 新冠肺炎 (COVID-19) 市场影响分析
  • 平均售价
  • 品牌占有率分析
  • 主要监理分析
  • 市占率分析
  • 专利情况
  • 监理指南
  • 价值链分析

第 4 章动态多导睡眠图 (PSG) 系统市场：依产品

  • 摘要
  • 少于 12 频道 PSG 系统
  • 少于 24 频道 PSG 系统
  • 少于 32 个频道的 PSG 系统
  • 32 个通道或更多

第 5 章动态多导睡眠图 (PSG) 系统市场：依应用划分

  • 摘要
  • 阻塞性睡眠
  • 呼吸暂停发作性睡病
  • 慢性失眠
  • 其他

第 6 章动态多导睡眠图 (PSG) 系统市场：依最终使用者划分

  • 摘要
  • 医院
  • 睡眠研究所
  • 居家照护环境

第 7 章门诊多导睡眠图 (PSG) 系统市场：依地区

  • 摘要
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 拉丁美洲/中东/非洲
    • 巴西
    • 阿拉伯联合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他领域

第八章竞争态势

  • 简介
  • 关键成功策略
  • 10家主要公司的产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要公司的定位

第九章公司简介

  • Koninklijke Philips N.V.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Nox Medical
  • Lowenstein Medical Technology GmbH+Co. KG.
  • neurosoft
  • Cadwell Industries Inc.
  • SOMNOmedics GmbH
  • Compumedics Limited
  • Compumedics Limited
Product Code: A31898

According to a new report published by Allied Market Research, titled, "Ambulatory Polysomnography (Psg) Systems Market," The ambulatory polysomnography (psg) systems market was valued at $327.00 million in 2021, and is estimated to reach $570.7 million by 2031, growing at a CAGR of 6% from 2022 to 2031.

Ambulatory Polysomnography Systems Market - IMG1

Ambulatory polysomnography (Amb-PSG), also known as type II PSG, can be used to identify different sleep disorders by characterizing sleep stages and quantifying arousals, total sleep time (TST), and an accurate respiratory disturbance index (RDI). Ambulatory polysomnography systems are in high demand among patients suffering from a variety of sleep disorders due to the benefits they provide. This is propelling the ambulatory polysomnography systems market.

The majority of the population, particularly in rural regions, is uninformed of the dangers of sleep apnea. Sleep disorders that go untreated can lead to chronic ailments like heart failure, stroke, high blood pressure, diabetes, and obesity. This can result in major health issues such as uncontrolled blood pressure, heart attacks, weakened and restricted blood vessels in the kidneys, and aneurysms. The population's lack of awareness about sleeping difficulties is expected to stymie the growth of the ambulatory polysomnography systems market in the near future.

Technological improvements in the sleep care business can be identified as a driving force in this market. The ambulatory polysomnography systems market is growing steadily due to numerous revolutionary technologies such as portable devices, smartphone applications, telemedicine, and so on. Wireless and portable polysomnography systems, like as Nox Medical's Nox A1s PSG, have benefited from research and development. Wireless capabilities give patients with a sense of liberty by allowing them freedom of movement while they are being diagnosed. This will have a beneficial impact on the growth of the ambulatory polysomnography systems market.

The global market has benefited by the outbreak of the COVID-19 pandemic. Key participants claimed considerable revenue growth as a result of an increase in the number of patients suffering from sleep difficulties as a result of the COVID19 pandemic. According to the poll, 70% of respondents have experienced one or more new sleep issues since the start of the COVID-19, leading to an increase in the use of sleep apnea equipment. As a result of this, the PSG systems' businesses launched a clinically certified, low-touch CPAP Mask Selector tool that can be utilized remotely from the patient's home.

The key players profiled in this report include: Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Lowenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ambulatory polysomnography (psg) systems market analysis from 2021 to 2031 to identify the prevailing ambulatory polysomnography (psg) systems market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ambulatory polysomnography (psg) systems market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global ambulatory polysomnography (psg) systems market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Up to 12 Channel PSG Systems
  • Up to 24 Channel PSG Systems
  • Up to 32 Channel PSG Systems
  • Above 32 Channel PSG Systems

By Application

  • Obstructive Sleep
  • Apnea Narcolepsy
  • Chronic Insomnia
  • Others

By End-user

  • Hospitals
  • Sleep Laboratories
  • Home Care Settings

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cadwell Industries Inc.
    • Compumedics Limited
    • Compumedics Limited
    • Koninklijke Philips N.V.
    • Lowenstein Medical Technology GmbH + Co. KG.
    • Natus Medical Incorporated
    • neurosoft
    • Nihon Kohden Corporation
    • Nox Medical
    • SOMNOmedics GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Average Selling Price
  • 3.7. Brand Share Analysis
  • 3.8. Key Regulation Analysis
  • 3.9. Market Share Analysis
  • 3.10. Patent Landscape
  • 3.11. Regulatory Guidelines
  • 3.12. Value Chain Analysis

CHAPTER 4: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Up to 12 Channel PSG Systems
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Up to 24 Channel PSG Systems
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Up to 32 Channel PSG Systems
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Above 32 Channel PSG Systems
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Obstructive Sleep
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Apnea Narcolepsy
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Chronic Insomnia
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Sleep Laboratories
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Home Care Settings
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End-user
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End-user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End-user
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End-user
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End-user
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End-user
      • 7.3.5.2. UK
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End-user
      • 7.3.5.3. France
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End-user
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End-user
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End-user
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End-user
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End-user
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End-user
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End-user
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End-user
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End-user
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End-user
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Product
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End-user
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End-user
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End-user
      • 7.5.5.2. United Arab Emirates
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End-user
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Product
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End-user
      • 7.5.5.4. South Africa
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Product
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End-user
      • 7.5.5.5. Rest of LAMEA
      • 7.5.5.5.1. Key market trends, growth factors and opportunities
      • 7.5.5.5.2. Market size and forecast, by Product
      • 7.5.5.5.3. Market size and forecast, by Application
      • 7.5.5.5.4. Market size and forecast, by End-user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Koninklijke Philips N.V.
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
  • 9.2. Natus Medical Incorporated
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
  • 9.3. Nihon Kohden Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
  • 9.4. Nox Medical
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
  • 9.5. Lowenstein Medical Technology GmbH + Co. KG.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
  • 9.6. neurosoft
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
  • 9.7. Cadwell Industries Inc.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
  • 9.8. SOMNOmedics GmbH
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
  • 9.9. Compumedics Limited
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
  • 9.10. Compumedics Limited
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 02. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 12 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 24 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR ABOVE 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 07. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OBSTRUCTIVE SLEEP, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR APNEA NARCOLEPSY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR CHRONIC INSOMNIA, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 12. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR SLEEP LABORATORIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 17. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 21. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 22. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 23. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 24. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 25. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 26. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 27. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 28. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 29. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 30. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 31. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 32. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 33. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 34. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 35. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 36. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 37. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 38. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 39. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 40. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 42. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 43. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 45. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 46. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 48. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 49. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 51. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 52. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 54. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 55. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 58. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 59. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 61. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 62. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 64. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 67. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 68. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 69. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 73. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 74. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 75. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 76. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 77. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 78. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 79. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 80. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 81. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 83. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 84. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 85. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 86. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 87. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 88. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 89. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 90. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 91. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
  • TABLE 92. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 93. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 94. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
  • TABLE 95. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
  • TABLE 96. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
  • TABLE 97. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • TABLE 98. NOX MEDICAL: KEY EXECUTIVES
  • TABLE 99. NOX MEDICAL: COMPANY SNAPSHOT
  • TABLE 100. LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: KEY EXECUTIVES
  • TABLE 101. LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: COMPANY SNAPSHOT
  • TABLE 102. NEUROSOFT: KEY EXECUTIVES
  • TABLE 103. NEUROSOFT: COMPANY SNAPSHOT
  • TABLE 104. CADWELL INDUSTRIES INC.: KEY EXECUTIVES
  • TABLE 105. CADWELL INDUSTRIES INC.: COMPANY SNAPSHOT
  • TABLE 106. SOMNOMEDICS GMBH: KEY EXECUTIVES
  • TABLE 107. SOMNOMEDICS GMBH: COMPANY SNAPSHOT
  • TABLE 108. COMPUMEDICS LIMITED: KEY EXECUTIVES
  • TABLE 109. COMPUMEDICS LIMITED: COMPANY SNAPSHOT
  • TABLE 110. COMPUMEDICS LIMITED: KEY EXECUTIVES
  • TABLE 111. COMPUMEDICS LIMITED: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET (2022-2031)
  • FIGURE 04. PORTER FIVE-1
  • FIGURE 05. PORTER FIVE-2
  • FIGURE 06. PORTER FIVE-3
  • FIGURE 07. PORTER FIVE-4
  • FIGURE 08. PORTER FIVE-5
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALAMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
  • FIGURE 10. IMPACT OF KEY REGULATION: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
  • FIGURE 11. MARKET SHARE ANALYSIS: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. REGULATORY GUIDELINES: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
  • FIGURE 15. VALUE CHAIN ANALYSIS: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
  • FIGURE 16. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 12 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 24 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 32 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR ABOVE 32 CHANNEL PSG SYSTEMS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 21. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OBSTRUCTIVE SLEEP, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR APNEA NARCOLEPSY, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR CHRONIC INSOMNIA, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 26. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR SLEEP LABORATORIES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 30. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET BY REGION, 2021
  • FIGURE 31. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 48. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 49. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 50. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 54. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 55. COMPETITIVE DASHBOARD
  • FIGURE 56. COMPETITIVE HEATMAP: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET
  • FIGURE 57. TOP PLAYER POSITIONING, 2021